In Q4 2025, operating expenses decreased to CAD 2.3 million from CAD 5.6 million in Q3 2025, due to reduced marketing and product development costs.1
Full-year 2025 operating expenses rose to CAD 16.1 million from CAD 8.1 million in 2024, driven by increased marketing and investor relations post-public listing.1
Cash balance as of December 31, 2025, was CAD 6.5 million, down from CAD 15.2 million at end of 2024, indicating need for better capital efficiency.1
Light AI's QuickScan™ Strep A application is commercially ready, with a dual-track strategy for clinical trials and regulatory approvals to capture market leadership.1
Sources:
1. https://intellectia.ai/news/stock/light-ai-reports-q4-2025-financial-results